Indegene Limited (NSEI: INDGN)
Health Care · Life Sciences Tools & Services · IN
Rs580.10
-2.26% today · +5.8% 1Y
Indegene Limited (NSEI: INDGN) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $1.44B and employs 4,687 people.
Over the last twelve months the share price has gained 5.8%, trading between 414.00 and 627.00.
Tweenvest scores Indegene Limited across four factors: quality 79/100, value 64/100, growth 86/100, dividend 43/100. Its strongest factor is growth.
INDGN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.44B
- Revenue (TTM)
- $403.25M
- P/E
- 34.92
- EPS
- 16.61
- Dividend yield
- 0.39%
- Beta (5Y)
- 0.75
- 52-week high
- Rs627.00
- 52-week low
- Rs414.00
- Avg volume (3M)
- —
- Shares outstanding
- 240.90M
- Employees
- 4,687
- Next earnings
- —
About Indegene Limited
Operating globally with a strong presence in India, Indegene Limited functions as a specialized commercialization partner for the life sciences industry. It provides comprehensive support to biopharmaceutical, emerging biotech, and medical device companies, assisting them from product development and market access to maximizing their impact throughout the product lifecycle. The company's service offerings include enterprise commercial, medical, and clinical solutions, coupled with omnichannel activation strategies and proprietary NEXT technology platforms. Indegene was established in 1998 and its principal operations are based in Bengaluru, India.
- ISIN
- INE065X01017
- Founded
- 1998
- Listed since
- May 13, 2024
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Personalis, Inc.NasdaqGM: PSNL | $1.71B | $15.87 | -0.81% |
| Azenta, Inc.NasdaqGS: AZTA | $1.65B | $37.13 | -1.56% |
| Peptron, Inc.KOSDAQ: A087010 | $1.59B | ₩91,500.00 | -29.34% |
| ChemoMetec A/SCPSE: CHEMM | $1.51B | Dkr587.50 | +0.17% |
| Syngene International LimitedNSEI: SYNGENE | $1.43B | Rs347.40 | -3.85% |
| Novogene Co., Ltd.SHSE: 688315 | $1.31B | CN¥21.73 | +9.91% |
| Akums Drugs and Pharmaceuticals LimitedNSEI: AKUMS | $1.19B | Rs751.85 | -7.53% |
| Beijing Hotgen Biotech Co., Ltd.SHSE: 688068 | $1.11B | CN¥84.54 | -10.51% |
Figures last refreshed Oct 11, 2026.